Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 Jun;48(6):539–544. doi: 10.1136/jcp.48.6.539

Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma.

J C Rockett 1, S J Darnton 1, J Crocker 1, H R Matthews 1, A G Morris 1
PMCID: PMC502684  PMID: 7665697

Abstract

AIM--To examine the expression of HLA-ABC and HLA-DR major histocompatibility (MHC) antigens and intercellular adhesion molecule (ICAM)-1 in normal, inflamed, metaplastic, and neoplastic oesophageal tissue and in freshly disaggregated tumours. METHODS--Sequential sections of frozen tissue and cytospins of freshly disaggregated tumour were stained using the ABC peroxidase system and monoclonal antibodies specific for HLA-ABC, HLA-DR and ICAM-1. RESULTS--Normal oesophageal tissue showed positive staining for HLA-ABC in the basal layers of the oesophageal squamous epithelium and on the epithelial cells of the submucosal oesophageal glands. HLA-DR and ICAM-1 were not detected in either of these cell types. In 20 of 37 (54%) carcinomas HLA-ABC was expressed weakly, with heterogeneous expression in nine (24%). Two tumours showed strong expression of HLA-ABC, but 15 of 37 (41%) were negative. HLA-DR and ICAM-1 were expressed weakly in six of 37 (16%) carcinomas without correlation with each other or with the expression of HLA-ABC. CONCLUSIONS--HLA-ABC is absent from a high proportion of oesophageal carcinomas (41%) and is otherwise variably and weakly expressed with strong expression in only a small fraction (3%). In other carcinomas there is a higher level of HLA-ABC expression. This discrepancy may partly explain the aggressive nature of oesophageal carcinomas. HLA-DR and ICAM-1 are not normally expressed on those cells from which oesophageal carcinomas are thought to arise. The limited expression found here could suggest a partial or inhibited immune response against oesophageal carcinoma. In vivo repressive factors may be involved.

Full text

PDF
539

Images in this article

540Image
on p.540
540Image
on p.540
541Image
on p.541
541Image
on p.541

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braciale T. J., Braciale V. L. Antigen presentation: structural themes and functional variations. Immunol Today. 1991 Apr;12(4):124–129. doi: 10.1016/0167-5699(91)90096-C. [DOI] [PubMed] [Google Scholar]
  2. Cabrera T., Concha A., Ruiz-Cabello F., Garrido F. Loss of HLA heavy chain and beta 2-microglobulin in HLA negative tumours. Scand J Immunol. 1991 Aug;34(2):147–152. doi: 10.1111/j.1365-3083.1991.tb01531.x. [DOI] [PubMed] [Google Scholar]
  3. Cabrera T., Garrido V., Concha A., Martín J., Esquivias J., Oliva M. R., Ruiz-Cabello F., Serrano S., Garrido F. HLA molecules in basal cell carcinoma of the skin. Immunobiology. 1992 Sep;185(5):440–452. doi: 10.1016/s0171-2985(11)80086-0. [DOI] [PubMed] [Google Scholar]
  4. Caces E., de Lauture H., Vol S., Tichet J., Boulard P. Le depistage systematique de la brucellose humaine par le test au Rose Bengale en milieu agricole d'apres une etude dans le centre-ouest de la France sur 89 000 exploitants et salaries. Comp Immunol Microbiol Infect Dis. 1978;1(1-2):107–114. doi: 10.1016/0147-9571(78)90017-6. [DOI] [PubMed] [Google Scholar]
  5. Cheng K. K., Day N. E., Davies T. W. Oesophageal cancer mortality in Europe: paradoxical time trend in relation to smoking and drinking. Br J Cancer. 1992 Apr;65(4):613–617. doi: 10.1038/bjc.1992.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Concha A., Cabrera T., Ruiz-Cabello F., Garrido F. Can the HLA phenotype be used as a prognostic factor in breast carcinomas? Int J Cancer Suppl. 1991;6:146–154. doi: 10.1002/ijc.2910470726. [DOI] [PubMed] [Google Scholar]
  7. Connor M. E., Stern P. L. Loss of MHC class-I expression in cervical carcinomas. Int J Cancer. 1990 Dec 15;46(6):1029–1034. doi: 10.1002/ijc.2910460614. [DOI] [PubMed] [Google Scholar]
  8. Csiba A., Whitwell H. L., Moore M. Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms. Br J Cancer. 1984 Nov;50(5):699–709. doi: 10.1038/bjc.1984.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Daar A. S., Fuggle S. V., Fabre J. W., Ting A., Morris P. J. The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation. 1984 Sep;38(3):287–292. doi: 10.1097/00007890-198409000-00018. [DOI] [PubMed] [Google Scholar]
  10. Daar A. S., Fuggle S. V., Fabre J. W., Ting A., Morris P. J. The detailed distribution of MHC Class II antigens in normal human organs. Transplantation. 1984 Sep;38(3):293–298. doi: 10.1097/00007890-198409000-00019. [DOI] [PubMed] [Google Scholar]
  11. Esteban F., Concha A., Delgado M., Pérez-Ayala M., Ruiz-Cabello F., Garrido F. Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx. Br J Cancer. 1990 Dec;62(6):1047–1051. doi: 10.1038/bjc.1990.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fleming K. A., McMichael A., Morton J. A., Woods J., McGee J. O. Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer. J Clin Pathol. 1981 Jul;34(7):779–784. doi: 10.1136/jcp.34.7.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Forsum U., Claesson K., Hjelm E., Karlsson-Parra A., Klareskog L., Scheynius A., Tjernlund U. Class II transplantation antigens: distribution in tissues and involvement in disease. Scand J Immunol. 1985 May;21(5):389–396. doi: 10.1111/j.1365-3083.1985.tb01823.x. [DOI] [PubMed] [Google Scholar]
  14. Garrido F., Cabrera T., Concha A., Glew S., Ruiz-Cabello F., Stern P. L. Natural history of HLA expression during tumour development. Immunol Today. 1993 Oct;14(10):491–499. doi: 10.1016/0167-5699(93)90264-L. [DOI] [PubMed] [Google Scholar]
  15. Glew S. S., Duggan-Keen M., Cabrera T., Stern P. L. HLA class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Res. 1992 Jul 15;52(14):4009–4016. [PubMed] [Google Scholar]
  16. Janossy G., Panayi G., Duke O., Bofill M., Poulter L. W., Goldstein G. Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet. 1981 Oct 17;2(8251):839–842. doi: 10.1016/s0140-6736(81)91107-7. [DOI] [PubMed] [Google Scholar]
  17. Johnson J. P., Stade B. G., Holzmann B., Schwäble W., Riethmüller G. De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci U S A. 1989 Jan;86(2):641–644. doi: 10.1073/pnas.86.2.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Johnson J. P. The role of ICAM-1 in tumor development. Chem Immunol. 1991;50:143–163. [PubMed] [Google Scholar]
  19. Klareskog L., Forsum U., Malmnäs Tjernlund U. K., Kabelitz D., Wigren A. Appearance of anti-HLA-DR-reactive cells in normal and rheumatoid synovial tissue. Scand J Immunol. 1981 Aug;14(2):183–192. doi: 10.1111/j.1365-3083.1981.tb00198.x. [DOI] [PubMed] [Google Scholar]
  20. Lampert I. A., Janossy G., Suitters A. J., Bofill M., Palmer S., Gordon-Smith E., Prentice H. G., Thomas J. A. Immunological analysis of the skin in graft versus host disease. Clin Exp Immunol. 1982 Oct;50(1):123–131. [PMC free article] [PubMed] [Google Scholar]
  21. López-Nevot M. A., Esteban F., Ferrón A., Gutiérrez J., Oliva M. R., Romero C., Huelin C., Ruiz-Cabello F., Garrido F. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas. Br J Cancer. 1989 Feb;59(2):221–226. doi: 10.1038/bjc.1989.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Maio M., Gulwani B., Langer J. A., Kerbel R. S., Duigou G. J., Fisher P. B., Ferrone S. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential. Cancer Res. 1989 Jun 1;49(11):2980–2987. [PubMed] [Google Scholar]
  23. Natali P., Nicotra M. R., Cavaliere R., Bigotti A., Romano G., Temponi M., Ferrone S. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res. 1990 Feb 15;50(4):1271–1278. [PubMed] [Google Scholar]
  24. Parkin D. M., Pisani P., Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993 Jun 19;54(4):594–606. doi: 10.1002/ijc.2910540413. [DOI] [PubMed] [Google Scholar]
  25. Redondo M., Concha A., Oldiviela R., Cueto A., Gonzalez A., Garrido F., Ruiz-Cabello F. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters. Cancer Res. 1991 Sep 15;51(18):4948–4954. [PubMed] [Google Scholar]
  26. Scott H., Brandtzaeg P., Solheim B. G., Thorsby E. Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin Exp Immunol. 1981 May;44(2):233–238. [PMC free article] [PubMed] [Google Scholar]
  27. Selby W. S., Janossy G., Mason D. Y., Jewell D. P. Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol. 1983 Sep;53(3):614–618. [PMC free article] [PubMed] [Google Scholar]
  28. Tufveson G., Forsum U., Claesson K., Klareskog L., Larsson E., Karlsson-Parra A., Frödin L. T-lymphocyte subsets and HLA-DR-expressing cells in rejected human kidney grafts. Scand J Immunol. 1983 Jul;18(1):37–40. doi: 10.1111/j.1365-3083.1983.tb00833.x. [DOI] [PubMed] [Google Scholar]
  29. Vogetseder W., Feichtinger H., Schulz T. F., Schwaeble W., Tabaczewski P., Mitterer M., Böck G., Marth C., Dapunt O., Mikuz G. Expression of 7F7-antigen, a human adhesion molecule identical to intercellular adhesion molecule-1 (ICAM-1) in human carcinomas and their stromal fibroblasts. Int J Cancer. 1989 May 15;43(5):768–773. doi: 10.1002/ijc.2910430504. [DOI] [PubMed] [Google Scholar]
  30. Zinkernagel R. M., Doherty P. C. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol. 1979;27:51–177. doi: 10.1016/s0065-2776(08)60262-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES